History

Side Navigation

Avixgen

History

  • Home
  • Avixgen
  • History
Now~2014
2017
A Phase 1b (Multiple ascending dose-MAD) trial of new anti-HIV therapeutic candidate (First-In-Class) in progress since Feb, 2017
In preparation for IND approval of Phase 1/2a trials of anti-cancer & anti-retinal disease drug candidates
2016
Completion of a Phase 1a (Single ascending dose-SAD) trial of new anti-HIV therapeutic candidate (First-In-Class)
Grant a project for High-tech Biomedical Research & Development / clinical research for two years from the Ministry of Health and Welfare
2015
Approved an Anti-HIV-1/AIDS Investigational New Drug (IND) in clinical phase 1 from MFDS
Funded from a number of venture capital investments (LB investment etc.)
2014
Approved as a Developmental orphan drug of new Anti-HIV-1/AIDS chemical drug from Ministry of Food and Drug Safety (MFDS).
2012~2006
2012
Granted a project for a preclinical Orphan drug development from Ministry of Health and Welfare
2011
Listed a patent for new anti-HIV chemical drugs in U.S.A.
2010
Granted a project for new global drug research and development and biotechnology by the Ministry of Education, Science and Technology of Korea (3 years)
2006
Listed a patent for AvicoreTM screening assay in U.S.A.
2005~2001
2005
Designated as a National Research Laboratory supported by the Ministry of Education,Science and Technology of Korea
2003
Granted a New Excellent Technology from Korea Evaluation Institute of Industrial Technology
Won a grand prize in Health Industry Technologies from Ministry of Health and Welfare
2002
Received Award for 30 research excellence from National Science Foundation
Received a grant from Small Medium Business Administration (SMBA)
2001
Received a research internship program in biotechnology from National Science Foundation
Approved as a Korean Venture Company
2000
Established Avixgen.Inc
Received a grant from the Ministry of Science & Technology